Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

Statement in response to the EU Council ratifying… 23 March 2018 Today’s agreement on a transition period is welcome news for…
EU-Canada Free Trade Agreement: an Opportunity to… 20 February 2017 Medicines for Europe welcomes the approval by the European Parliament…
Biosimilars at work: Access. Experience. Science. 1 April 2017 Biosimilar medicines are a part of today’s therapeutic armamentarium –…
The European Biosimilars Group Appoints New… 10 February 2016 Last week in Brussels, the European Biosimilar medicines Group (EBG…